The company hopes that the availability of an effective treatment such
as FabiFlu will considerably help assuage this pressure, and offer
patients in India a much needed and timely therapy option, he added.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-launches-covid-19-drug-after-dcgi-nod/articleshow/76479268.cms
No comments:
Post a Comment